Details for New Drug Application (NDA): 208383
✉ Email this page to a colleague
NDA 208383 describes BEVYXXA, which is a drug marketed by Portola Pharms Inc and is included in one NDA. There are five patents protecting this drug. Additional details are available on the BEVYXXA profile page.
The generic ingredient in BEVYXXA is betrixaban. Additional details are available on the betrixaban profile page.
The generic ingredient in BEVYXXA is betrixaban. Additional details are available on the betrixaban profile page.
Summary for 208383
| Tradename: | BEVYXXA |
| Applicant: | Portola Pharms Inc |
| Ingredient: | betrixaban |
| Patents: | 5 |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for 208383
Generic Entry Date for 208383*:
Constraining patent/regulatory exclusivity:
Dosage:
CAPSULE;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 40MG | ||||
| Approval Date: | Jun 23, 2017 | TE: | RLD: | Yes | |||||
| Patent: | ⤷ Subscribe | Patent Expiration: | Nov 8, 2026 | Product Flag? | Substance Flag? | Y | Delist Request? | ||
| Patent: | ⤷ Subscribe | Patent Expiration: | Mar 29, 2031 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
| Patented Use: | INHIBITING COAGULATION | ||||||||
| Patent: | ⤷ Subscribe | Patent Expiration: | Sep 8, 2028 | Product Flag? | Substance Flag? | Delist Request? | |||
| Patented Use: | PROPHYLAXIS OF DEEP VEIN THROMBOSIS (DVT) | ||||||||
Expired US Patents for NDA 208383
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-002 | Jun 23, 2017 | ⤷ Subscribe | ⤷ Subscribe |
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | ⤷ Subscribe | ⤷ Subscribe |
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-002 | Jun 23, 2017 | ⤷ Subscribe | ⤷ Subscribe |
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | ⤷ Subscribe | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
